Andres Gomez: This is why we developed a phase 2 study with outpatient ven-aza instead of 7+3

Andres Gomez, Associate Professor at the Autonomous University of Nuevo León, Monterrey, Mexico, posted on X/Twitter:

“This is why we developed a phase 2 study with outpatient ven-aza instead of 7+3 and why Yadith Lopez will present a poster comparing pre-post outcomes in the American Society of Hematology 23.

AML in India commentary The Lancet Haematology mirrors Mexico.”

For the article click here.
Source: Andres Gomez/Twitter